<?xml version="1.0" encoding="UTF-8"?>
<p>There are two studies for developing vaccines against SFTSV infection (Dong et al., 
 <xref rid="B15" ref-type="bibr">2019</xref>; Kwak et al., 
 <xref rid="B33" ref-type="bibr">2019</xref>). A recombinant vesicular stomatitis virus expressing SFTSV antigen completely protected mice from SFTSV infection (Dong et al., 
 <xref rid="B15" ref-type="bibr">2019</xref>). A DNA vaccine expressing antigens of SFTSV, elicited both neutralizing antibody response and SFTSV-specific T cell response and protected aged-ferrets from the lethal SFTSV infection (Kwak et al., 
 <xref rid="B33" ref-type="bibr">2019</xref>). Safe and effective vaccines against SFTS should be developed.
</p>
